FDA Panel Endorses Johnson & Johnson Vaccine Booster Doses

WASHINGTON, DC — In a unanimous decision, an independent panel for the U.S. Food and Drug Administration on Friday officially endorsed booster doses of the Johnson & Johnson COVID-19 vaccine, according to a report by The Washington Post.

The recommendation applies to anyone 18 and older who received the one-dose vaccine at least two months prior to getting a booster shot. The recommendation will now be reviewed by the FDA, which is expected to make a decision in a matter of days, the Post reported.

Nearly 14 million Americans have received the J&J vaccine, which studies have shown offers the weakest protection against COVID-19 compared to the Moderna and Pfizer-BioNTech vaccines — 71 percent compared to 93 and 88 percent, respectively.

The endorsement comes a day after the panel offered a similar recommendation on booster doses of the Moderna vaccine.

Read more via The Washington Post